These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2851649)

  • 1. [Cytotoxic effector cells specific for Epstein-Barr nuclear antigen positive nasopharyngeal hybrid cells are present in patients with infectious mononucleosis].
    Furukawa M; Kamide M; Ikeda C; Sakasita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1988 Nov; 91(11):1831-6. PubMed ID: 2851649
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
    Rickinson AB
    Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E; Masucci MG
    Springer Semin Immunopathol; 1982; 5(1):63-73. PubMed ID: 6314570
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G; Rickinson AB
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH; Fleischer B
    Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis].
    Urazova LN; Podoplekin VD; Odintsova LN; Lepekhin AV
    Lab Delo; 1989; (5):73-4. PubMed ID: 2473271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 8. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the antibody response to BamHI-K nuclear antigen in uncomplicated infectious mononucleosis.
    Niederman JC; Miller G
    J Infect Dis; 1986 Aug; 154(2):346-9. PubMed ID: 3014015
    [No Abstract]   [Full Text] [Related]  

  • 10. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
    Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic significance of antibodies to the Epstein-Barr virus-specific membrane antigen gp250.
    Jilg W; Wolf H
    J Infect Dis; 1985 Jul; 152(1):222-5. PubMed ID: 2989385
    [No Abstract]   [Full Text] [Related]  

  • 12. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
    J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human monoclonal autoantibody isolated from a patient with infectious mononucleosis reactive with both self antigens and Epstein-Barr virus nuclear antigen (EBNA).
    Garzelli C; Pacciardi A; Carmignani M; Conaldi G; Basolo F; Falcone G
    Immunol Lett; 1989 Sep; 22(3):211-6. PubMed ID: 2478456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
    Robinson JE
    Yale J Biol Med; 1982; 55(3-4):311-6. PubMed ID: 6295008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the Epstein-Barr virus in human pathology].
    Rupniewska ZM
    Acta Haematol Pol; 1979; 10(3):183-91. PubMed ID: 228518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serological diagnosis of infectious mononucleosis caused by Epstein-Barr virus].
    de Ory F
    Enferm Infecc Microbiol Clin; 1991 Jan; 9(1):63-4. PubMed ID: 1851444
    [No Abstract]   [Full Text] [Related]  

  • 19. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T-lymphocyte clones specific for an immunodominant epitope display discerning antagonistic response to naturally occurring Epstein-Barr virus variants.
    Khanna R; Burrows SR; Silins SL; Moss DJ; Poulsen LM; Burrows JM
    J Virol; 1996 Oct; 70(10):7306-11. PubMed ID: 8794388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.